tiprankstipranks
Percheron Therapeutics (AU:PER)
ASX:PER
Holding AU:PER?
Track your performance easily

Percheron Therapeutics (PER) Financial Statements

10 Followers

Percheron Therapeutics Financial Overview

Percheron Therapeutics's market cap is currently ―. The company's EPS TTM is AU$-0.014; its P/E ratio is -5.38; Percheron Therapeutics is scheduled to report earnings on February 26, 2025, and the estimated EPS forecast is AU$-0.01. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Jun 21Jun 20Jun 19Jun 18
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsAU$ 19.23MAU$ 6.02MAU$ 4.06MAU$ 2.90MAU$ 4.30M
Total AssetsAU$ 22.44MAU$ 7.00MAU$ 5.35MAU$ 3.70MAU$ 4.80M
Total DebtAU$ 227.40KAU$ 306.85KAU$ 135.26KAU$ 0.00AU$ 0.00
Net DebtAU$ -19.01MAU$ -5.71MAU$ -3.92MAU$ -2.90MAU$ -4.30M
Total LiabilitiesAU$ 1.30MAU$ 1.27MAU$ 821.23KAU$ 888.84KAU$ 580.86K
Stockholders EquityAU$ 21.14MAU$ 5.73MAU$ 4.53MAU$ 2.81MAU$ 4.22M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in AUD

Percheron Therapeutics Earnings and Revenue History

Percheron Therapeutics Debt to Assets

Percheron Therapeutics Cash Flow

Percheron Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis